Literature DB >> 3843690

Undifferentiated and poorly differentiated carcinoma.

J Rosai, E A Saxén, L Woolner.   

Abstract

Undifferentiated (anaplastic) thyroid carcinoma is a highly aggressive neoplasm which may simulate microscopically a variety of soft tissue sarcomas. The three major subtypes are spindle cell, giant cell, and squamoid. Electron microscopic examination and immunocytochemical stain for cytokeratin are the most useful special techniques to document the epithelial nature of the tumor. Undifferentiated small-cell carcinoma is a term to be discarded. Nearly all tumors so designated in the past are malignant lymphomas, small-cell variants of medullary carcinomas, or poorly differentiated (insular) carcinomas. Poorly differentiated (insular) carcinoma is a thyroid malignant tumor characterized by the formation of solid nests and small follicles, a monotonous growth of small cells of follicular derivation, mitotic activity, necrosis, and peritheliomatous formation. Immunocytochemically, it is negative for calcitonin and positive for thyroglobulin. It is a clinically aggressive neoplasm, which metastasizes to both regional lymph nodes and distant organs. It is probably analogous to the tumor described by Langhans in 1907 as "wuchernde Struma."

Entities:  

Mesh:

Year:  1985        PMID: 3843690

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  13 in total

Review 1.  Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland.

Authors:  Jatin P Shah
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-11       Impact factor: 2.503

2.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?

Authors:  Tihana Ibrahimpasic; Ronald Ghossein; Diane L Carlson; Iain J Nixon; Frank L Palmer; Snehal G Patel; Robert M Tuttle; Ashok Shaha; Jatin P Shah; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-04-17       Impact factor: 5.344

4.  Paucicellular variant of anaplastic thyroid carcinoma: report of two cases.

Authors:  J C Canos; A Serrano; X Matias-Guiu
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Immunohistochemical analysis of amylase isoenzymes in thyroid cancer.

Authors:  M Higashiyama; S Doi; N Tomita; T Monden; M Murotani; Y Kawasaki; T Kobayashi; T Shimano; M Ogawa; S Takai
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

6.  Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.

Authors:  Iwao Sugitani; Kazuhisa Toda; Noriko Yamamoto; Atsuhiko Sakamoto; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 7.  Surgical options in undifferentiated thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

8.  p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas.

Authors:  X Matias-Guiu; M Cuatrecasas; E Musulen; J Prat
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

9.  Anaplastic thyroid carcinoma with rhabdomyoblastic differentiation: a case report with a good clinical outcome.

Authors:  Marijke Olthof; Adrienne C M Persoon; John T M Plukker; Jacqueline E van der Wal; Thera P Links
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

10.  Prognostic factors of anaplastic thyroid carcinoma.

Authors:  J Y Jiang; F Y Tseng
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.